In Vivo Zymosan Treatment Induces IL15-Secreting Macrophages and KLRG1-Expressing NK Cells in Mice
Molecules · 2023
DOI: 10.3390/molecules28155779 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Hyun Jung Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Bioscience and Biotechnology, Institute of Anticancer Medicine Development, Sejong University, Seoul 05006, Republic of Kor…. Hauptthemen laut MEDLINE: Interleukin-15, beta-Glucans. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Research Foundation of Korea.
Abstract (Originalsprache)
Beta-glucan (β-glucan) is a natural polysaccharide produced by fungi, bacteria, and plants. Although it has been reported that β-glucan enhances innate immune memory responses, it is unclear whether different types of β-glucans display similar immune effects. To address this issue, we employed zymosan (β-1,3-glycosidic linkage) and pustulan (β-1,6-glycosidic linkage) to investigate their in vivo effects on innate memory immune responses. We examined the changes of innate memory-related markers in macrophages and natural killer (NK) cells, two immune cell types that display innate memory characteristics, at two different time points (16 h and 7 days) after β-glucan stimulation. We found that short-term (16 h) zymosan treatment significantly induced macrophages to upregulate IL15 production and increased surface IL15Rα expression on NK cells. In addition, long-term (7 days) zymosan treatment significantly induced macrophages to upregulate the expression of innate memory-related markers (e.g., TNFα, HIF1α, and mTOR) and induced NK cells to express enhanced levels of KLRG1, known as an innate memory-like marker. Our results provide support that zymosan can be an effective adjuvant to promote innate memory immune responses, providing a bridge between innate and adaptive immune cells to enhance various immune responses such as those directed against tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrative Bioscience and Biotechnology, Institute of Anticancer Medicine Development, Sejong University, Seoul 05006, Republic of Korea.
- Department of Biomedical Laboratory Science, College of Health and Biomedical Services, Sangji University, Wonju 26339, Republic of Korea.
- Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
ORCID-Profile: Hyun Jung Park, Sung Won Lee, Yun Hoo Park, Tae-Cheol Kim, Luc Van Kaer, Seokmann Hong
Förderung
- NIDDK NIH HHS
- National Research Foundation of Korea
Zitieren
APA
Park, H. J., Lee, S. W., Park, Y. H., Kim, T. C., Lee, S., Lee, S., Van Kaer, L., & Hong, S. (2023). In Vivo Zymosan Treatment Induces IL15-Secreting Macrophages and KLRG1-Expressing NK Cells in Mice. Molecules. https://doi.org/10.3390/molecules28155779
Vancouver
Park HJ, Lee SW, Park YH, Kim TC, Lee S, Lee S, et al. In Vivo Zymosan Treatment Induces IL15-Secreting Macrophages and KLRG1-Expressing NK Cells in Mice. Molecules. 2023. doi:10.3390/molecules28155779
BibTeX
@article{Park2023,
author = {Park, Hyun Jung and Lee, Sung Won and Park, Yun Hoo and Kim, Tae-Cheol and Lee, Sujin and Lee, Seyeong and Van Kaer, Luc and Hong, Seokmann},
title = {In Vivo Zymosan Treatment Induces IL15-Secreting Macrophages and KLRG1-Expressing NK Cells in Mice},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28155779}
}
EUVIMED